NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Shanmu Biotechnology

Shanmu Biotechnology

Private
ShenzhenHealthcare & Life Scienceshttps://shanmu.ltd/

Last Round

Series A

May 6, 2026

Total Funding Raised

$22.2M

Company Overview

Shanmu Biotechnology is a health technology company that develops AI-powered, miniaturized medical robots for automated, non-invasive at-home urine analysis and chronic disease management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Consumer Electronics

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

at-home urine analysismedical robotsmart toilethealth monitoringmicrofluidicsspectral analysisbiomarker trackingchronic illness managementconsumer health-techdigital healthremote patient monitoringRPMhealth IoTpreventive medicinewearable alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanmu Biotechnology Comps

Public and private peers based on sector, stage, and business model.

Shanmu Biotechnology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shanmu Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 6, 2026
VC RoundJan 1, 2026
Pre SeedOct 1, 2025
Pre SeedJun 18, 2025
VC RoundJun 1, 2025
Pre Seed
Jun 6, 2024

Shanmu Biotechnology Investors

Notable investors and investment history

Shanmu Biotechnology investors
InvestorRounds
iCANX FundPre Seed
松禾资本 (Green Pine Capital Partners)Pre Seed
Songlin GroupPre Seed
Bojiang CapitalSeries A

Shanmu Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanmu Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanmu Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2020
Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.